rotational atherectomy (PTCRA (-) group), and 55 patients underwent CABG (CABG group). The chosen revascularization method was based largely on the number of diseased vessels and the severity of the coronary artery calcification. For example, patients with triple-vessel or left main trunk disease underwent bypass surgery, and those with onevessel disease underwent PCI. In the PCI group, patients with lesions showing severe calcification that seemed to be impossible to dilate with a balloon and a calcified arc ≥270°on intravascular ultrasound (IVUS) were selected for PTCRA, whereas others had PCI without rotational atherectomy. In patients with two-vessel disease, treatment was selected on the basis of the patient's wishes and consideration of the perioperative risk (preoperative estimation of risk was done using the ACC/AHA Guidelines for CABG surgery and the history of cerebral infarction). 19, 20 As a result, 14 patients with two-vessel disease underwent CABG.
Procedure
PTCRA The initial burr size was 1.5 or 1.75 mm and the speed ranged from 140,000 to 180,000 rpm. Ablation was performed using a pecking motion, avoiding a decrease in the rotational speed of the burr by greater than 5,000 rpm. Long lesions were divided into segments and each segment was ablated separately. The burr-to-artery ratio was intended to be approximately 0.75. To prevent coronary spasm and slow flow, boluses of nitroglycerin and nicorandil were administered. 21 Adjuvant percutaneous transluminal coronary angioplasty was performed using a balloon to artery ratio of 1.1:1 at a lower pressure for 30 s. Intravascular ultrasound (IVUS) was performed in all patients. Intracoronary stenting was performed for 32 lesions (52%), because of coronary dissection. A total of 39 stents were used. A Palmaz-Schatz stent, Tristar stent, Bx veloci- ty stent, and Terumo stent were implanted in one lesion each. Multi-link stents were used in 7 lesions, as well as GFX stents in 8 lesions, and NIR stents in 20 lesions. Procedural success was defined as a final angiographic residual diameter stenosis ≤30%. Follow-up angiography was performed at 6 months after PTCRA or earlier if recurrence of symptoms and/or electrocardiographic (ECG) changes were noted.
PCI Without Rotational Atherectomy Intracoronary stenting was performed for 28 lesions (93%) because of coronary dissection and/or coronary recoil. A total of 28 stents were used. Palmaz-Schatz stents were implanted in 3 lesions, Multi-link stents in 7 lesions, GFX stents in 8 lesions, and NIR stents in 10 lesions. Follow-up angiography was done as already outlined.
CABG Arterial grafts were used whenever possible. Coronary angiography was done after the bypass surgery and just before the patient was discharged. Graft patency was defined as stenosis <50%.
Follow-up
Baseline clinical data and in-hospital outcomes were obtained by review of the hospitalization records and procedural reports. Major adverse clinical events, defined as death, myocardial infarction (MI) or repeat revascularization, were investigated for all patients by reviewing the clinical records or by telephone. MI was defined as the development of new Q waves on a 12-lead ECG or a more than 2-fold increase of creatine kinase-MB above the upper limit of the normal range.
PTCRA (+) PTCRA (-) CABG

Diabetes mellitus 24 (55%) 14 (54%) 25 (49%) Chronic glomerulonephritis 12 (27%) 5 (19%) 21 (38%)
Hypertension 6 (14%) 5 (19%) 5 ( 9%) Cystic kidney 0 ( 0%) 2 ( 8%) 0 ( 0%) SLE 1 ( 2%) 0 ( 0%) 0 ( 0%) RA 0 ( 0%) 0 ( 0%) 1 ( 2%) Cholesterol embolism 0 ( 0%) 0 ( 0%) 1 ( 1%) Pregnancy 1 ( 2%) 0 ( 0%) 0 ( 0%)
Quantitative Coronary Angiography
Quantitative coronary angiography was performed using QCA-CMS (MEDIS, Leiden, the Netherlands). Intracoronary nitroglycerin was administered before the initial, final, and follow-up angiograms to achieve maximal vasodilatation. The outer diameter of the catheter was used as a calibration standard.
Statistical Analysis
Continuous variables were displayed as the mean ± SD and analyzed using the unpaired Student's t-test and ANOVA. Categorical data were presented as the frequency and analyzed using the chi-square test or Fisher's exact test. Event-free survival curves were constructed using KaplanMeier product-limit estimates and were compared using the log-rank test. Probability values of less than 0.05 were considered statistically significant. All statistical analyses were conducted using SAS version 6.12 software (SAS Institute, Cary, NC, USA).
Results
Patient Characteristics
The baseline characteristics of the subjects are shown in Table 1 . Multivessel disease was common in the CABG group. The CABG risk score (ACC/AHA) was higher and the duration of dialysis was longer in the PTCRA (+) group than in the CABG or PTCRA (-) groups. The causes of chronic renal failure are shown in Table 2 . Half of the subjects had end-stage renal disease because of diabetes mellitus.
Procedural Outcome
The results of PCI are shown in Table 3 and those of CABG are shown in Table 4 . In the PTCRA (+) group, the target lesions were more complex and had more severe calcification than the lesions of PTCRA (-) group. The incidence of type C lesions was 41% in the PTCRA (+) group versus 27% in the PTCRA (-) group and severely calcified lesions were found in 92% versus 0%, respectively. The initial success rate of PTCRA was 98%. The mean burr/artery ratio was 0.77 and the mean balloon/artery ratio was 1.1. Stents were used for 32 lesions (52%) and the mean stent diameter was 3.4±0.5 mm. Failure of PTCRA occurred in only 1 case in which the Rota-wire ® ('Rotablator angioplasty system' Boston Scientific Corporation) could not cross the lesion, therefore the patient underwent PCI without rotational atherectomy. In the PTCRA (-) group, the lesion success rate was 100% and the mean balloon artery ratio was 1.1. Stents were used for 28 lesions (93%) and the mean stent diameter was 3.4±0.5 mm. In the CABG group, the total number of bypass grafts was 146 (2.7 per patient), including 61 arterial grafts (1.1 per patient). Follow-up coronary angiography (CAG) was performed in 48 patients (87%) and the overall graft patency rate was 93%. Table 5 shows the clinical results. There were 6 hospital deaths, comprising 2 patients (5%) from the PTCRA (+) group, 1 (4%) from the PTCRA (-) group, and 3 (5%) from the CABG group. The hospital death rates were not statistically different among the groups. The duration of hospital stay for the PTCRA (+) group was one-quarter of that for the CABG group (13±17 days for the PTCRA (+) group, 8.9±7.3 days for the PTCRA (-) group, and 60±35 days for the CABG group, p=0.0001). The perioperative complica- tion rate was 11% (2 congestive heart failure, 1 Q-MI, 1 nonQ-MI, 1 infection) in the PTCRA (+) group and 4% (1 nonQ-MI) in the PTCRA (-) group. On the other hand, the rate for the CABG group was 42% (1 Q-MI, 12 infections, 5 gastrointestinal bleeding, 3 cerebrovascular disease, 2 agranulocytosis, 1 liver dysfunction, 1 obstruction of arteriovenous dialysis access, and 1 hemothorax), which was significantly higher than in the PTCRA (+) or PTCRA (-) groups (p=0.001). Perioperative complications were mainly noncardiac in the CABG group and cardiac in the PTCRA (+) group.
In-Hospital Clinical Outcome
Follow-up Clinical Outcome
The mean follow-up period was 20±14 months in the PTCRA (+) group, 22±15 months in the CABG group, and 23±11 months in the PTCRA (-) group (NS). Causes of death are shown in Table 6 . Overall death, cardiac death, and MI showed no significant differences among the 3 groups, but the rates of cardiac death and MI were higher in the PTCRA (+) group than in the PTCRA (-) group or the CABG group. Follow-up CAG was performed after 4.7± 2.7 months in 41 patients with 57 lesions from the PTCRA (+) group, and 27 lesions (45%) in 20 patients needed repeat revascularization. The rate of repeat revascularization was higher in the PTCRA (+) group and PTCRA (-) group than in the CABG group (p=0.001). According to the Kaplan -Meier analysis, the event-free survival rates without death (Fig 1A) and without death or MI (Fig 1B) were not statistically different among the 3 groups. In contrast, the event-free survival rate without death, MI or repeat revascularization was significantly higher in the CABG group than in the PTCRA (+) group or PTCRA (-) group (p=0.0004; Fig 1C) .
Discussion
It has been reported that in dialysis patients CABG is superior to PCI using unstented balloon angioplasty. [1] [2] [3] [4] [5] [6] [7] Coronary stenting seems to be more effective than balloon angioplasty alone, [8] [9] [10] 22 but CABG is still superior to stenting based on a large retrospective study of 15,784 dialysis patients in the United States. 11 One reason for this is the presence of severely calcified coronary lesions in dialysis patients, 23 which neither the balloon nor the coronary stent can adequately dilate. The Rotablator ® is a unique interventional tool that is capable of enlarging severely calcified vessels, but to our knowledge there has not been a previous report focusing on the use of rotational atherectomy as treatment for cardiac conditions of dialysis patients.
Even though the present PTCRA group had a higher CABG risk score and a longer duration of dialysis, that group had a shorter hospital stay and lower complication rate than the CABG group. In particular, the 42% rate of noncardiac perioperative complications after CABG is not acceptable for some high-risk patients. In-hospital complications were mainly noncardiac in the CABG group compared with cardiac complications in the PTCRA group, half of which were attributable to congestive heart failure (CHF) during the early period. The cause of that CHF may have been inappropriate management of dialysis because it decreased after we changed the protocol to remove excess water 24 h before PTCRA. During the follow-up period, event-free survival without death or MI showed no statistical difference between the PTCRA and CABG groups. However, CABG was superior to PTCRA with regard to event-free survival without death, MI, or repeat revascularization because of the higher restenosis rate in the PTCRA group. During follow-up, 20 patients (45%) needed repeat revascularization of the target lesion in the PTCRA group and 4 patients developed acute MI because of restenosis. Although there was no statistical difference, the cardiac death rate of the PTCRA group was higher than that of the CABG group, probably because of the higher restenosis rate, despite the use of the Rotablator ® and the low rate of complete revascularization. We previously reported that the prognosis of dialysis patients with coronary artery disease was determined by whether or not they achieved complete revascularization. 24 The present results indicate that PTCRA is superior to CABG in the short term, but inferior over the long term. Coronary artery brachytherapy 25, 26 and drug-eluting stents have been suggested as promising methods to reduce restenosis. [27] [28] [29] It is possible that a combination of rotational atherectomy and these methods could achieve better results than CABG in the future.
In conclusion, PTCRA seems to be a safe alternative for revascularization in high-risk CABG candidates who have severely calcified complex coronary lesions that are resistant to balloon dilatation. The present study was done at a single center and was nonrandomized and retrospective in design. Therefore, a multicenter randomized study is needed to confirm these findings.
